Display Settings:

Format

Send to:

Choose Destination
    J Diabetes Sci Technol. 2009 May 1;3(3):492-9.

    Can technology improve adherence to long-term therapies?

    Source

    Department of Endocrinology, Diabetes and Metabolic Diseases, Avicenne Hospital, Bobigny, France. gerard.reach@avc.aphp.fr

    Abstract

    BACKGROUND:

    Therapeutic nonadherence is defined as the lack of equivalence between the behavior of the patients and their prescribed medical treatment. Consequences of nonadherence include not only health outcomes, but also cost saving. Thus, this issue gets paramount importance in contemporary medicine.

    METHOD:

    The aim of this article is to discuss the relationships between technology and adherence by asking the following three questions. (1) How can technology be used to monitor patient adherence? (2) Considering the mechanisms of nonadherence in chronic diseases, is there room for technology in interventions aimed to improve patient adherence? (3) What about adherence to technology in diabetes care?

    RESULTS AND CONCLUSION:

    Technology may help improve adherence to long-term therapies by (1) giving a concrete representation of adherence rewards, (2) overcoming immediate obstacles to adherence, such as the fear of hypoglycemia, and (3) providing an opportunity for patient-doctor conversations. This assumes, however, that both the patient and the doctor are convinced that technologies are useful.

    2009 Diabetes Technology Society.

    PMID:
    20144287
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2769863
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1.
    Figure 2.

      Supplemental Content

      Icon for Diabetes Technology Society Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk